FDA and CDC explain J&J vaccine pause, say blood clots ‘appear to be extremely rare’

Leaders from the FDA and CDC announced in a press call that the Johnson & Johnson recommendation is being made “out of an abundance of caution” after learning of six cases of “a rare and severe type of blood clot” after vaccination.